India's first Ayurvedic anti-diabetic drug, BGR-34, launched by CSIR

Feb 4, 2016 10:33 IST

Council for Scientific and Industrial Research (CSIR) on 3 February 2016 launched the BGR-34, the country's first anti-diabetic ayurvedic drug for Diabetes. BGR is acronym for blood glucose regulator.

The ayurvedic drug BGR-34 was launched at Kozhikode, Kerala by CSIR's Senior Principal Scientist Dr AKS Rawat as part of the Global Ayurveda Festival in the city.


BGR-34 is designed for type 2 Diabetes mellitus, has been scientifically validated for its efficacy and safety. Priced at 5 rupees per tablet, the medicine is now available at all major chemist counters of Kerala.

The drug works by controlling blood sugar level (anti-hyperglycaemic property) and limiting the harmful effects of other drugs and is not toxic in nature nor carries any side-effects.

The drug was developed by CSIR in collaboration with National Botanical Research Institute and Central Institute for Medicinal and Aromatic Plant. It was developed as diabetes has become a major threat in the health sector and about 6 crore of adult Indian population has been found to be diabetic and there is no effective solution for the disease yet.

Now get latest Current Affairs on mobile, Download # 1  Current Affairs App

Is this article important for exams ? Yes39 People Agreed

DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK